| Literature DB >> 30106998 |
Natasa Pilipovic-Broceta1,2, Nadja Vasiljevic3, Jelena Marinkovic4, Nevena Todorovic1,2, Janko Jankovic5, Irena Ostric6, Dimitra Kalimanovska-Ostric6,7, Maja Racic8.
Abstract
The objectives of this study were to evaluate patients' attitudes towards hypertension treatment according to the chronic care model and to assess the implementation of hypertension clinical guidelines in family medicine. The cross-sectional study was carried out in two randomly selected primary health care centers (Bijeljina and Prijedor), respectively in Bosnia and Herzegovina, covering the period between March and April 2016. This study sample consists of 791 respondents with hypertension purposing to measure specific actions and quality of care for hypertensive patients. The Patient Assessment of Chronic Illness Care (PACIC) was used. Treatment for the indicators of hypertension was assessed by analyzing patients' medical charts according to the recommendations of clinical guidelines. More than half of the evaluated indicators of treatment for hypertension were documented in medical charts of 84.07% patients. The average overall PACIC score was 4.18 (SD 0.59), being an average of the separate scores of 4.19 (SD 0.57) in men and 4.17 (SD 0.60) in women. Subscale means of PACIC were as follows: patient activation 4.33, delivery system design 4.36; goal setting 4.03; problem solving 4.51; follow-up and co-ordination 3.67. No statistically significant correlations in the overall score and subscale scores were found by demographic characteristics. Non-smokers had a significantly higher overall score compared to smokers (p = 0.001). As implementation of the guidelines became stronger, the reported PACIC scores rose. Continuing the education of patients in order to achieve better health care outcomes is imperative.Entities:
Mesh:
Year: 2018 PMID: 30106998 PMCID: PMC6091945 DOI: 10.1371/journal.pone.0202250
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Socio-demographic characteristics of respondents.
| Characteristic | N | % |
|---|---|---|
| < 55 | 151 | 19.3 |
| 55–64 | 259 | 33.2 |
| 65+ | 371 | 47.5 |
| Male | 303 | 38.3 |
| Female | 488 | 61.7 |
| With partner | 568 | 72.1 |
| Without partner | 220 | 27.9 |
| Primary | 325 | 42.0 |
| Secondary | 352 | 45.5 |
| Tertiary | 96 | 12.4 |
| Employed | 138 | 17.5 |
| Non—employed | 159 | 20.2 |
| Retired | 302 | 38.3 |
| Student | 4 | 0.5 |
| Housewife | 167 | 21.2 |
| Other | 19 | 2.4 |
| Urban | 291 | 36.8 |
| Semi–urban | 162 | 20.5 |
| Rural | 337 | 42.7 |
| No | 665 | 84.9 |
| Yes | 118 | 15.1 |
| Normal /(18.50–24.99) | 175 | 23.3 |
| >25 (overweight) | 306 | 40.7 |
| >30 (obese) | 271 | 36.0 |
| Excellent | 115 | 14.6 |
| Good | 289 | 36.8 |
| Bad | 381 | 48.5 |
| None | 17 | 2.2 |
| Once to four times | 292 | 37.2 |
| Five to ten times | 277 | 35.2 |
| More than ten times | 200 | 25.4 |
BMI: body mass index
The relationship between patient characteristics and hypertension guideline indicators.
| Patient characteristics | Indicators registered in medical charts (percent) | Normal indicator findings (percent) | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <25 | 25–49.99 | 50–74.99 | ≥75 | Total | <25 | 25–49.99 | 50–74.99 | ≥75 | Total | |||||||||||||
| N (%) | 25 | (54.3) | 27 | (33.8) | 10 | (36.) | 121 | (39.2) | 303 | (38.3) | 40 | (43.0) | 138 | (39.5) | 122 | (35.7) | 3 | (42.9) | 303 | (38.3) | ||
| N (%) | 21 | (45.7) | 53 | (66.3) | 226 | (63.5) | 188 | (60.8) | 488 | (61.7) | 53 | (57.0) | 211 | (60.5) | 220 | (64.3) | 4 | (57.1) | 488 | (61.7) | ||
| N (%) | 46 | (100) | 80 | (100) | 356 | (100) | 309 | (100) | 791 | (100) | 93 | (100) | 349 | (100) | 342 | (100) | 7 | (100) | 791 | (100) | ||
| Mean (SD) | 63.8 | (14.2) | (10.3) | 627 | (10.5) | 635 | (9.5) | 63.3 | (10.3) | 65.7 | (11.5) | 63.1 | (10.8) | 62.8 | (9.4) | 66.1 | (12.7) | 63.3 | (10.3) | |||
| N (%) | 11 | (25.0) | 14 | (17.9) | 78 | (22.3) | 48 | (15.5) | 151 | (19.3) | 16 | (17.8) | 72 | (21.0) | 62 | (18.2) | 1 | (14.3) | 151 | (19.3) | ||
| N (%) | 6 | (13.6) | 21 | (26.9) | 107 | (30.6) | 125 | (40.5) | 259 | (33.2) | 14 | (15.6) | 109 | (31.8) | 134 | (39.3) | 2 | (28.6) | 259 | (33.2) | ||
| N (%) | 27 | (61.4) | 43 | (55.1) | 165 | (47.1) | 136 | (44.0) | 371 | (47.5) | 60 | (66.7) | 162 | (47.2) | 145 | (42.5) | 4 | (57.1) | 371 | (47.5) | ||
| Total | N (%) | 44 | (100) | 78 | (100) | 350 | (100) | 309 | (100.0) | 781 | (100) | 90 | (100) | 343 | (100) | 341 | (100) | 7 | (100) | 781 | (100) | |
| N (%) | 43 | (93.5) | 69 | (87.3) | 294 | (83.8) | 259 | (84.4) | 665 | (84.9) | 81 | (88.0) | 297 | (86.1) | 280 | (82.6) | 7 | (100.0) | 665 | (84.9) | ||
| N (%) | 3 | (6.5) | 10 | (12.7) | 57 | (16.2) | 48 | (15.6) | 118 | (15.1) | 11 | (12.0) | 48 | (13.9) | 59 | (17.4) | 0 | (0.0) | 118 | (15.1) | ||
| N (%) | 46 | (100) | 79 | (100) | 351 | (100) | 307 | (100) | 783 | (100) | 92 | (100) | 345 | (100) | 339 | (100) | 7 | (100) | 783 | (100) | ||
| N (%) | 8 | (17.4) | 4 | (5.1) | 49 | (13.9) | 54 | (17.5) | 115 | (14.6) | 11 | (12.0) | 40 | (11.6) | 63 | (18.5) | 1 | (14.3) | 115 | (14.6) | ||
| N (%) | 15 | (32.6) | 44 | (55.7) | 132 | (37.5) | 98 | (31.8) | 289 | (36.8) | 42 | (45.7) | 138 | (39.9) | 106 | (31.2) | 3 | (42.9) | 289 | (36.8) | ||
| N (%) | 23 | (50.0) | 31 | (39.2) | 171 | (48.6) | 156 | (50.6) | 381 | (48.5) | 39 | (42.4) | 168 | (48.6) | 171 | (50.3) | 3 | (42.9) | 381 | (48.5) | ||
| N (%) | 46 | (100) | 79 | (100) | 352 | (100) | 308 | (100) | 785 | (100) | 92 | (100) | 346 | (100) | 340 | (100) | 7 | (100) | 785 | (100) | ||
| N (%) | 1 | (2.2) | 4 | (5.0) | 10 | (2.8) | 2 | (0.7) | 17 | (2.2) | 0 | (0.0) | 11 | (3.2) | 6 | (1.8) | 0 | (0.0) | 17 | (2.2) | ||
| N (%) | 19 | (41.3) | 39 | (48.8) | 130 | (36.8) | 104 | (33.9) | 292 | (37.2) | 39 | (41.9) | 128 | (36.9) | 123 | (36.3) | 2 | (28.6) | 292 | (37.2) | ||
| N (%) | 8 | (17.4) | 24 | (30.0) | 121 | (34.3) | 124 | (40.4) | 277 | (35.2) | 25 | (26.9) | 123 | (35.4) | 125 | (36.9) | 4 | (57.1) | 277 | (35.2) | ||
| N (%) | 18 | (39.1) | 13 | (16.3) | 92 | (26.1) | 77 | (25.1) | 200 | (25.4) | 29 | (31.2) | 85 | (24.5) | 85 | (25.1) | 1 | (14.3) | 200 | (25.4) | ||
| N (%) | 46 | (100) | 80 | (100) | 353 | (100) | 307 | (100) | 786 | (100) | 93 | (100) | 347 | (100) | 339 | (100) | 7 | (100) | 786 | (100) | ||
PACIC overall and subscales scores in patients with hypertension in family medicine.
| Patient characteristics | PACIC | PACIC subscales | ||||
|---|---|---|---|---|---|---|
| Patient activations (Q1-Q3) | Delivery system design/decision support (Q4-Q6) | Goal setting/tailoring (Q7-Q11) | Problem solving/contextual (Q12-Q15) | Follow-up/coordination (Q16-Q20) | ||
| < 25.00 | 3.96(0.76) | 4.20(0.90) | 4.02(0.79) | 3.84 (0.95) | 4.43 (0.77) | 3.54 (1.01) |
| 25.00–49.99 | 3.93(0.53) | 4.13(0.71) | 4.00(0.64) | 3.73 (0.70) | 4.27 (0.67) | 3.48(0.84) |
| 50.00–74.99 | 4.17(0.58) | 4.29(0.76) | 4.35(0.66) | 4.00 (0.82) | 4.51 (0.53) | 3.65 (0. 89) |
| ≥ 75.00 | 4.28(0.56) | 4.43(0.66) | 4.50(0.59) | 4.15(0.76) | 4.57 (0.55) | 3.76 (0.87) |
| P-value | 0.001 | 0.002 | 0.001 | 0.001 | 0.001 | 0.049 |
| < 25.00 | 3.95(0.65) | 4.17(0.83) | 4.01(0.76) | 3.84(0.79) | 4.36 (0.69) | 3.49 (0.89) |
| 25.00–49.99 | 4.16(0.58) | 4.34(0.71) | 4.36(0.63) | 3.98 (0.84) | 4.48 (0.59) | 3.69 (0.89) |
| 50.00–74.99 | 4.25(0.56) | 4.36(0.72) | 4.44(0.63) | 4.11 (0.75) | 4.56 (0.52) | 3.70 (0.89) |
| ≥ 75.00 | 4.34(0.69) | 4.43(0.63) | 4.48(0.60) | 4.00 (0.98) | 4.64 (0.40) | 3.91 (1.03) |
| P-valuea | 0.001 | 0.145 | 0.001 | 0.021 | 0.013 | 0.191 |
| no | 4.20(0.58) | 4.36(0.72) | 4.38(0.65) | 4.06 (0.81) | 4.53 (0.57) | 3.72 (0.88) |
| yes | 4.00(0.58) | 4.16(0.76) | 4.22(0.70) | 3.85(0.78) | 4.37 (0.59) | 3.44 (0.89) |
| P-value | 0.001 | 0.010 | 0.026 | 0.010 | 0.009 | 0.002 |
| Self–reported health | ||||||
| Excellent | 4.32 (0.52) | 4.43 (0.07) | 4.54 (0.05) | 4.22 (0.74) | 4.54 (0.51) | 3.90 (0.85) |
| Good | 4.17(0.06) | 4.34 (0.70) | 4.35(0.59) | 4.04 (0.78) | 4.51(0.52) | 3.69(0.87) |
| Bad | 4.14 (0.62) | 4.29 (0.76) | 4.30 (0.72) | 3.95 (0.83) | 4.49(0.63) | 3.59(0.91) |
| P-value | 0.009 | 0.144 | 0.003 | 0.008 | 0.700 | 0.005 |
| Blood pressure | ||||||
| Systolic | ||||||
| >140 mmHg | 4.02 (0.65) | 4.21 (0.80) | 4.17 (0.74) | 3.83 (0.872) | 4.42 (0.71) | 3.43 (0.97) |
| <140 mmHg | 4.22 (0.55) | 4.37 (0.70) | 4.42 (0.63) | 4.87 (0.77) | 4.53(0.53) | 3.74 (0.85) |
| P-value | 0.001 | 0.018 | 0.001 | 0.001 | 0.075 | 0.001 |
| >90 mmHg | 3.88 (0.67) | 4.09 (0.97) | 4.10 (0.83) | 3.60(0.79) | 4.34(0.67) | 3.23 (0.92) |
| < 90 mmHg | 4.21 (0.568) | 4.35 (0.69) | 4.39 (0.64) | 4.07 (0.79) | 4.52 (0.57) | 3.71 (0.88) |
| P-value | 0.001 | 0.039 | 0.011 | 0.001 | 0.143 | 0.001 |
a ANOVA test
bStudent t-test
Differences in PACIC scores according to the values of clinical parameters.
| Parameter | Number of participants with registered value | PACIC | p | ||
|---|---|---|---|---|---|
| Mean | SD | ||||
| Serum glucose | >6.5 mmol/ | 160 | 4.22 | 0.52 | 0.597 |
| <6.5 mmol/l | 524 | 4.19 | 0.59 | ||
| Cholesterol | >5 mmol/l | 425 | 4.19 | 0.59 | 0.490 |
| <5 mmol/l | 238 | 4.22 | 0.52 | ||
| HDL- cholesterol | < 1.2 F; 1 M mmol/l | 186 | 4.28 | 0.53 | 0.305 |
| > 1.2 F;1 M mmol/l | 114 | 4.35 | 0.58 | ||
| LDL-cholesterol | >3.4 mmol/l | 287 | 4.27 | 0.56 | 0.648 |
| <3.4 mmol/l | 253 | 4.25 | 0.55 | ||
| Triglycerides | >1.7 mmol/l | 331 | 4.22 | 0.566 | 0.388 |
| <1.7 mmol/l | 330 | 4.18 | 0.574 | ||
| Hemoglobin | <120 F, 140 M g/l | 174 | 4.27 | 0.523 | 0.129 |
| >120 F, 140 M | 497 | 4.19 | 0.593 | ||
| Creatinine | <44 F, 62 M μmol/l | 161 | 4.07 | 0.607 | 0.000 |
| >80 F,106 M μmol/l | 464 | 4.28 | 0.551 | ||
| Proteinuria | >150 mg/24h | 25 | 4.04 | 0.721 | 0.638 |
| <150 mg/24h | 117 | 4.11 | 0.597 | ||
| BMI | >25 kg/m2 | 269 | 4.18 | 0.584 | 0.611 |
| <25 kg/m2 | 476 | 4.16 | 0.588 | ||
| Waist circumference (cm) | > 88 F, 102 M | 195 | 4.22 | 0.533 | 0.004 |
| < 88 F, 102 M | 226 | 4.37 | 0.502 | ||
BMI: Body Mass Index; F: female; M: male
aStudent t-test
Antihypertensive therapy.
| Medication class | n | % | 95%CI |
|---|---|---|---|
| ACE inhibitors | 373 | 47.2 | 43.4–51.0 |
| Combinations ACE inhibitors/diuretics | 320 | 40.5 | 36.7–44.3 |
| Calcium channel blockers | 252 | 31.9 | 28.3–35.5 |
| Beta blockers | 144 | 18.3 | 15.3–21.3 |
| Diuretics | 71 | 9.0 | 6.8–11.2 |
95%CI: confidence interval